The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fractionated dose radiolabeled anti−prostate specific membrane antigen (PSMA) radioimmunotherapy (177Lu−J591) for progressive metastatic castration−resistant prostate cancer (mCRPC).
 
Jaspreet S. Batra
No Relationships to Disclose
 
Beerinder S. Karir
No Relationships to Disclose
 
Kavya Pinto-Chengot
No Relationships to Disclose
 
Yuliya Jhanwar
No Relationships to Disclose
 
Shankar Vallabhajosula
No Relationships to Disclose
 
Paul J. Christos
No Relationships to Disclose
 
Gillian Hodes
No Relationships to Disclose
 
Linda Lam
No Relationships to Disclose
 
Ana M. Molina
Honoraria - ASCO
Consulting or Advisory Role - AVEO; Bayer/Onyx
Research Funding - Eisai (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Eisai
 
Himisha Beltran
Consulting or Advisory Role - Bayer
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst)
 
David M. Nanus
No Relationships to Disclose
 
Stanley J. Goldsmith
No Relationships to Disclose
 
Neil Harrison Bander
Consulting or Advisory Role - BIND Therapeutics; BZL Biologics
Patents, Royalties, Other Intellectual Property - Cornell Univ
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst); Progenics (Inst); Sanofi (Inst)